Literature DB >> 3603622

Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro.

J B Chinnery, D L Morris.   

Abstract

Hydatid protoscoleces obtained from sheep (infected with Echinococcus granulosus) were treated in culture medium with albendazole sulphoxide at final concentrations of 100, 500 and 1000 micrograms/l and the viability was assessed at regular intervals. Over a period of up to 31 days concentrations of 500 and 1000 micrograms/l of sulphoxide significantly reduced the viability in treated groups, as compared with appropriate controls, whilst 100 micrograms/l of sulphoxide had no effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3603622     DOI: 10.1016/0035-9203(86)90392-5

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  14 in total

1.  Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes.

Authors:  K Ingold; P Bigler; W Thormann; T Cavaliero; B Gottstein; A Hemphill
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  In vitro effects of flubendazole on Echinococcus granulosus protoscoleces.

Authors:  M Elissondo; M Dopchiz; L Ceballos; L Alvarez; S Sánchez Bruni; C Lanusse; G Denegri
Journal:  Parasitol Res       Date:  2005-12-22       Impact factor: 2.289

3.  In vitro and in vivo effects of flubendazole on Echinococcus granulosus metacestodes.

Authors:  M Elissondo; L Ceballos; M Dopchiz; V Andresiuk; L Alvarez; S Sánchez Bruni; C Lanusse; G Denegri
Journal:  Parasitol Res       Date:  2006-12-15       Impact factor: 2.289

4.  Cytokine gene expression in peripheral blood mononuclear cells (PBMC) from patients with pharmacologically treated cystic echinococcosis.

Authors:  R Riganò; E Profumo; B Buttari; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 5.  Diagnosis and treatment of human hydatidosis.

Authors:  H Wen; R R New; P S Craig
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

6.  Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis.

Authors:  R Riganò; E Profumo; S Ioppolo; S Notargiacomo; A Teggi; A Siracusano
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

7.  In vitro protoscolicidal effects of fungal chitosan isolated from Penicillium waksmanii and Penicillium citrinum.

Authors:  Mahdi Fakhar; Aroona Chabra; Bahman Rahimi-Esboei; Fatemeh Rezaei
Journal:  J Parasit Dis       Date:  2013-05-15

8.  Flubendazole and ivermectin in vitro combination therapy produces a marked effect on Echinococcus granulosus protoscoleces and metacestodes.

Authors:  M Celina Elissondo; L Ceballos; L Alvarez; S Sánchez Bruni; C Lanusse; G Denegri
Journal:  Parasitol Res       Date:  2009-05-15       Impact factor: 2.289

9.  Anti-tubulin immunohistochemistry study of Echinococcus granulosus protoscolices incubated with albendazole and albendazole sulphoxide in vitro.

Authors:  J Pérez-Serrano; G Denegri; N Casado; G Bodega; F Rodríguez-Caabeiro
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

10.  Antibody responses to in vitro translation products following albendazole therapy for Echinococcus granulosus.

Authors:  R E Blanton; G B Okelo; J Kijobe; C H King
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.